01450nas a2200241 4500000000100000008004100001260005600042653001600098653001900114653001100133653001100144653001200155100001600167700001900183700001300202700001600215245006100231856026000292300000800552490000800560520061500568022002501183 2026 d c03/2026bMJS Publishing, Medical Journals Sweden AB10aCase report10aDrug Eruptions10aSweden10aMimick10aleprosy1 aAlvergren G1 aHammarström H1 aPolyza S1 aJohansson I00aA Rare Case of Leprosy in Sweden Mimicking Drug Eruption uhttps://scholar.google.nl/scholar_url?url=https://medicaljournalssweden.se/actadv/article/download/45640/53049&hl=nl&sa=X&d=14406051931857080685&ei=aM6qaYDSJs-NieoPoP7bYQ&scisig=AFtJQiweI_jOy78gV9N9btesNW-E&oi=scholaralrt&hist=732gnZIAAAAJ:250456702282544 a1-30 v1063 a

Leprosy (morbus Hansen), caused by Mycobacterium leprae, remains a global health concern in endemic regions, with approximately 200,000 new cases reported annually. In contrast, it is exceedingly rare in Northern Europe, where only sporadic cases are seen. We report a patient with widespread cutaneous
lesions diagnosed as lepromatous leprosy in Sweden. This case underscores the crucial role of healthcare professionals in nonendemic regions to maintain a high index of suspicion for leprosy when evaluating patients from endemic areas who present with unexplained skin lesions or neuropathy.

 a1651-2057, 0001-5555